口服抗凝剂对骨骼健康的影响(系统文献综述)

H.V. Mostbauer, T.A. Karasevska, L.P. Antonenko, Iu.V. Rudenko, A.B. Bezrodnyi
{"title":"口服抗凝剂对骨骼健康的影响(系统文献综述)","authors":"H.V. Mostbauer, T.A. Karasevska, L.P. Antonenko, Iu.V. Rudenko, A.B. Bezrodnyi","doi":"10.22141/pjs.13.3.2023.386","DOIUrl":null,"url":null,"abstract":"Background. Osteoporosis is actually today's problem, as it affects the quality and length of life, and increases the risk of fragility fractures, which leads to significant medical, social, and economic problems. One of the reasons for the development of secondary osteoporosis is the use of vitamin K and new oral anticoagulants, the use of which is increasing. The purpose of this review was to analyze of literature data regarding the impact of oral anticoagulants on the bone state, the risk of osteoporosis and its complications in order to improve the awareness of doctors of various specialties. Materials and methods. The lite­rature review was carried out based on the analysis of scientometric databases PubMed, Google Scholar, and Scopus using the keywords “vitamin K antagonists”; “warfarin; “osteoporosis”; “osteoporotic fracture”; “non-vitamin K antagonist oral anticoagulants”; “systematic review” for the period 2013-2023, but it did not exclude key works that were published earlier. The search was performed by two independent authors. 160 sources were selec­ted for analysis, of which 53 were used that met the search criteria. ­Results. The ana­lysis of researches showed that the effects of vitamin K antagonists and new oral anticoagulants on bone and the risk of fragility fractures are controversial. Nevertheless, the new oral anticoagulants in comparison to vitamin K antagonists seem to have a less negative effect on bone and the lowest risk of fragility fractures. The mechanism of such influence is still under examination. Conclusions. Most studies have demonstrated the adverse effects of vitamin K antagonists on bone health. A lower risk of fractures was observed with new oral anticoagulants than with vitamin K antagonists, in particular, warfarin. Taking into account the analyzed data of the literature, it is recommended to also assess the risk of fragility fractures when prescribing vitamin K antagonists or new oral anticoagulants.","PeriodicalId":31851,"journal":{"name":"Bol'' Sustavy Pozvonocnik","volume":"78 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2023-10-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Effects of oral anticoagulants on bone health (systematic literature review)\",\"authors\":\"H.V. Mostbauer, T.A. Karasevska, L.P. Antonenko, Iu.V. Rudenko, A.B. Bezrodnyi\",\"doi\":\"10.22141/pjs.13.3.2023.386\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Background. Osteoporosis is actually today's problem, as it affects the quality and length of life, and increases the risk of fragility fractures, which leads to significant medical, social, and economic problems. One of the reasons for the development of secondary osteoporosis is the use of vitamin K and new oral anticoagulants, the use of which is increasing. The purpose of this review was to analyze of literature data regarding the impact of oral anticoagulants on the bone state, the risk of osteoporosis and its complications in order to improve the awareness of doctors of various specialties. Materials and methods. The lite­rature review was carried out based on the analysis of scientometric databases PubMed, Google Scholar, and Scopus using the keywords “vitamin K antagonists”; “warfarin; “osteoporosis”; “osteoporotic fracture”; “non-vitamin K antagonist oral anticoagulants”; “systematic review” for the period 2013-2023, but it did not exclude key works that were published earlier. The search was performed by two independent authors. 160 sources were selec­ted for analysis, of which 53 were used that met the search criteria. ­Results. The ana­lysis of researches showed that the effects of vitamin K antagonists and new oral anticoagulants on bone and the risk of fragility fractures are controversial. Nevertheless, the new oral anticoagulants in comparison to vitamin K antagonists seem to have a less negative effect on bone and the lowest risk of fragility fractures. The mechanism of such influence is still under examination. Conclusions. Most studies have demonstrated the adverse effects of vitamin K antagonists on bone health. A lower risk of fractures was observed with new oral anticoagulants than with vitamin K antagonists, in particular, warfarin. Taking into account the analyzed data of the literature, it is recommended to also assess the risk of fragility fractures when prescribing vitamin K antagonists or new oral anticoagulants.\",\"PeriodicalId\":31851,\"journal\":{\"name\":\"Bol'' Sustavy Pozvonocnik\",\"volume\":\"78 1\",\"pages\":\"0\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2023-10-13\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Bol'' Sustavy Pozvonocnik\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.22141/pjs.13.3.2023.386\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Bol'' Sustavy Pozvonocnik","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.22141/pjs.13.3.2023.386","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

摘要

背景。骨质疏松症实际上是当今的问题,因为它影响生活质量和寿命,并增加脆性骨折的风险,从而导致重大的医疗、社会和经济问题。继发性骨质疏松症发展的原因之一是维生素K和新型口服抗凝剂的使用,其使用正在增加。本综述的目的是分析口服抗凝剂对骨状态、骨质疏松及其并发症风险的影响的文献资料,以提高各专科医生的认识。材料和方法。生命性质综述基于科学计量数据库PubMed、Google Scholar和Scopus进行分析,关键词为“维生素K拮抗剂”;“华法林;“骨质疏松症”;“骨质疏松性骨折”;“非维生素K拮抗剂口服抗凝剂”;2013-2023年期间的“系统评价”,但不排除更早发表的关键作品。这项研究是由两位独立的作者进行的。我们选择了160个来源进行分析,其中53个符合搜索标准。结果。研究分析表明,维生素K拮抗剂和新型口服抗凝剂对骨的影响和脆性骨折的风险存在争议。然而,与维生素K拮抗剂相比,新的口服抗凝剂似乎对骨骼的负面影响较小,脆性骨折的风险最低。这种影响的机制仍在研究中。结论。大多数研究已经证明了维生素K拮抗剂对骨骼健康的不利影响。新的口服抗凝剂比维生素K拮抗剂,特别是华法林,骨折的风险更低。考虑到文献分析的数据,建议在处方维生素K拮抗剂或新的口服抗凝剂时也评估脆性骨折的风险。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Effects of oral anticoagulants on bone health (systematic literature review)
Background. Osteoporosis is actually today's problem, as it affects the quality and length of life, and increases the risk of fragility fractures, which leads to significant medical, social, and economic problems. One of the reasons for the development of secondary osteoporosis is the use of vitamin K and new oral anticoagulants, the use of which is increasing. The purpose of this review was to analyze of literature data regarding the impact of oral anticoagulants on the bone state, the risk of osteoporosis and its complications in order to improve the awareness of doctors of various specialties. Materials and methods. The lite­rature review was carried out based on the analysis of scientometric databases PubMed, Google Scholar, and Scopus using the keywords “vitamin K antagonists”; “warfarin; “osteoporosis”; “osteoporotic fracture”; “non-vitamin K antagonist oral anticoagulants”; “systematic review” for the period 2013-2023, but it did not exclude key works that were published earlier. The search was performed by two independent authors. 160 sources were selec­ted for analysis, of which 53 were used that met the search criteria. ­Results. The ana­lysis of researches showed that the effects of vitamin K antagonists and new oral anticoagulants on bone and the risk of fragility fractures are controversial. Nevertheless, the new oral anticoagulants in comparison to vitamin K antagonists seem to have a less negative effect on bone and the lowest risk of fragility fractures. The mechanism of such influence is still under examination. Conclusions. Most studies have demonstrated the adverse effects of vitamin K antagonists on bone health. A lower risk of fractures was observed with new oral anticoagulants than with vitamin K antagonists, in particular, warfarin. Taking into account the analyzed data of the literature, it is recommended to also assess the risk of fragility fractures when prescribing vitamin K antagonists or new oral anticoagulants.
求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
CiteScore
0.10
自引率
0.00%
发文量
23
审稿时长
10 weeks
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信